MedTrace Logo

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

NCT01135355 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-06-21

No results posted yet for this study

Summary

The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.

Conditions

  • Blood Stem Cell Transplant Failure

Sponsors & Collaborators

Principal Investigators

  • Rajni Agarwal-Hashmi · Stanford University

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-12-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01135355 on ClinicalTrials.gov